[ad_1]
Torrent Pharmaceuticals Limited has expanded the recall of its losartan potbadium tablets USP. Originally, the company recalled 10 batches of this drug. The company's officials added another six batches of Losartan potbadium and hydrochlorothiazide tablets after the discovery of traces of N-nitrosodiethylamine (NDEA) in one of the active ingredients of the pill, announced the Food and Drug Administration.
>> Read more new trends
NDEA is a naturally occurring substance found in certain foods, water, air pollution and some industrial processes. It has been clbadified as probable carcinogen for humans.
The recall only concerns products that contain more than the acceptable amount of NDEA, according to the FDA.
Patients on the recalled pills are advised to continue taking them until they contact their doctor or pharmacist for alternative treatment, the FDA announced in its press release.
The following tablets are covered by the Torrent Pharmaceuticals Recall:
- LOSARTAN POTASSIUM TAB, USP 100 mg, 30 dose vials, NOC number 13668-115-30, lot BO31C016, expiry date 04/2019.
- LOSARTAN POTASSIUM TAB, USP 100 mg, bottles 90 units, NDC number 13668-115-90, lot BO31C016, expiry date 04/2019.
- LOSARTAN POTASSIUM TAB, USP 100 mg vials 1000 pieces, NDC number 13668-115-10, lot 4DK3C005, expiry date 4/2019.
- LOSARTAN POTASSIUM TAB, USP 100 mg vials 1000, NOC number 13668-115-10, lot 4DK3C004, expiry date 4/2019.
- LOSARTAN POTASSIUM TAB, USP 100 mg vials 1000, NOC number 13668-115-10, lot 4DU3C040, expiry date 10/2019.
- LOSARTAN POTASSIUM TAB, USP 100 mg, Flasks 1000 units, number NDC 13668-
115-10, lot 4DU3E049, expiry date 5/2021. - LOSARTAN POTASSIUM TAB, USP 100 mg vials 1000, NOC number 13668-115-10, lot 4DU3E050, expiry date 5/2021.
- LOSARTAN POTASSIUM TAB, USP 50 mg, 30 dose vials, NOC number 13668-409-30, lot 4L67C035, expiry date 10/2019.
- LOSARTAN POTASSIUM TAB, USP 50 mg, bottles 90 units, NDC number 13668-409-90, lot 4L67C035, expiry date 10/2019.
- LOSARTAN POTASSIUM TAB, USP 50 mg, bottles 90 units, NDC number 13668-409-90, lot 4L67C036, expiration date 10/2019
- LOSARTAN POTASSIUM TAB, USP 50 mg vials 1000 units, NDC number 13668-409-10, lot 4O50C005, expiry date 11/2019.
- LOSARTAN POTASSIUM TAB, USP 25 mg, bottles 90 units, NDC number 13668-113-90, lot 4O49C013, expiry date 9/2019.
- TABLETS OF POTASSIUM AND LOSARTAN HYDROCHOLOROTHIAZIDE, USP 50 mg / 12.5 mg, vials of 90 doses, NOC number 13668-116-90, lot BP02C008, expiry date 3/2019.
- TABLETS OF POTASSIUM AND LOSARTAN HYDROCHOLOROTHIAZIDE, USP 50 mg / 12.5 mg, vials of 1000 units, NDC number 13668-116-10, lot BEF7D006, expiry date 3/2020.
- TABLETS OF POTASSIUM AND LOSARTAN HYDROCHOLOROTHIAZIDE, USP 100 mg / 12.5 mg, 90-dose vials, NDC number 13668-117-90, lot BX35C020, expiry date 5/2019.
- TABLETS OF POTASSIUM AND LOSARTAN HYDROCHOLOROTHIAZIDE, USP 100 mg / 12.5 mg, 90-dose vials, NOC number 13668-117-90, lot BX35C049, expiration date 8/2019.
- LOSARTAN POTASSIUM AND HYDROCHOLOROTHIAZIDE TABLETS, USP 100 mg / 12.5 mg, 1000-dot vials, NOC number 13668-117-10, lot BX35C022, expiry date 5/2019.
- TABLETS OF POTASSIUM AND LOSARTAN HYDROCHOLOROTHIAZIDE, USP 100 mg / 12.5 mg, vials with 1,000 counts, NDC number 13668-117-10, lot BX35C023, expiration date 5/2019.
Those who may have medical questions regarding the recall or who wish to report a reaction to the drug should call 1-800-912-9561 or send an e-mail to [email protected].
© 2019 Cox Media Group.
[ad_2]
Source link